Biomedicina predictiva e investigación traslacional de las enfermedades respiratorias, cardiovasculares y metabólicas
BIOPRE
Pfizer (United States)
Nueva York, Estados UnidosPublicacions en col·laboració amb investigadors/es de Pfizer (United States) (10)
2021
-
Health and economic impact of the correct diagnosis of transthyretin cardiac amyloidosis in Spain
Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 21, Núm. 5, pp. 1127-1133
2017
-
Cardiovascular efficacy and safety of bococizumab in high-risk patients
New England Journal of Medicine, Vol. 376, Núm. 16, pp. 1527-1539
-
Cost-effectiveness and cost-utility analysis of apixaban versus dabigatran and rivaroxaban in the treatment and secondary prevention of venous thromboembolism
Pharmacoeconomics - Spanish Research Articles, Vol. 14, Núm. 1, pp. 7-18
2016
-
Cost-effectiveness analysis of apixaban compared to low-molecular-weight heparins and Vitamin K antagonists for treatment and secondary prevention of venous thromboembolism
Farmacia Hospitalaria, Vol. 40, Núm. 3, pp. 187-208
2007
-
Directrices para el desarrollo y la evaluación de guías terapéuticas: Elementos y recomendaciones para su diseño y elaboración
Medicina Clinica, Vol. 128, Núm. 3, pp. 100-110
-
Impacto de la EPOC en la vida diaria de los pacientes. Resultados del estudio multicéntrico EIME
Archivos de Bronconeumologia, Vol. 43, Núm. 2, pp. 64-72
2006
-
Chronic respiratory symptoms, spirometry and knowledge of COPD among general population
Respiratory Medicine, Vol. 100, Núm. 11, pp. 1973-1980
2003
-
A six-month, multicenter, open-label, noncomparative, prospective, observational study of the efficacy and tolerability of atorvastatin in the primary care setting (Estudio del Control de las Hiperlipidemias en Atención Primaria): The CHEAP study
Current Therapeutic Research - Clinical and Experimental, Vol. 64, Núm. 6, pp. 338-354
-
Synergistic effect of angiotensin-converting enzyme (ACE) and 3-hydroxy-3-methyl-glutaryl-CoA (HMG-CoA) reductase inhibition on inflammatory markers in atherosclerotic rabbits
Clinical Science, Vol. 105, Núm. 6, pp. 655-662
2000
-
Effect of atorvastatin on endothelium-dependent constrictor factors in dyslipidemic rabbits
General Pharmacology: The Vascular System, Vol. 34, Núm. 4, pp. 263-272